Beccar Varela‘s well-established life sciences practice provides pharmaceutical, medical devices, cosmetics, healthcare services and digital health companies with a full-service offering that includes coverage of commercial matters, IP, litigation, licensing and M&A in the industry. The firm is particularly well known for its deep regulatory expertise, and is called on for support with clinical trials, drug approvals, and issues related to post-trial access to study drugs. Other active areas include work involving orphan drugs, Argentina’s exceptional access regime for pharmaceuticals, and medicinal cannabis. Practice head Ana Andrés is well regarded and recognised for her deep knowledge of healthcare regulation. Senior associate Malvina Acuña focuses on healthcare and life sciences and handles a mix of transactional, corporate and company law work.
L’éditorial du Legal 500
- Profil
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘The practice provides effective and business-oriented advice that is responsive to the needs of the client’
‘Ana Andrés leads the team in a professional and cost-effective manner.'
‘The team has good knowledge of sector regulations and there is effective coordination between the firm's specialist lawyers.’
‘The team stands out for its great knowledge of the industry and absolute dedication to the projects it works on.’
‘Down-to-earth attorneys who offer precise advice and commercial awareness.’
‘It is a pleasure to work with Ana Andrés, who is extremely professional and smart.’
'Ana Andrés is a very competent and objective lawyer, who conducts her analyses in a practical manner that is aligned with the corporate environment and language. She is always contributing strategically to the company's business.'
'Ana Andrés is very available, knows the company's business as well as the law, and provides much-appreciated advice from a risk mitigation point of view.'
Clients clés
- GlaxoSmithKline/Haleon
- Abbvie
- Biomarin
- Cámara Argentina de Especialidades Medicinales
- PTC Therapeutics
- Sanofi Group
- B Braun Medical
- Biosidus
- Penumbra
- GSK Biopharma
Points forts
- Advised and assisted Opella with the transfer of its Hidrotisona family of products to Eurofarma Brazil.
- Advised Mega Labs on the acquisition of Dromex Biotech.
Avocats
Les grands avocats de demain
Jeunes associés disposant d’une reconnaissance montante sur le marché, jouant régulièrement un rôle clé dans des dossiers majeurs.
Responsable de la pratique
Ana Andrés